Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris-Stephan Rauchmann

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2024
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathiesRoxane Dilcher, Stephan Wall, Mattes Groß, et al.
NPJ Digital Medicine|June 10, 2026
Smartphone-based detection of subtle memory decline in prodromal Alzheimer's diseaseSarah E Polk, Lindsay R Clark, Kristin Basche, et al.
Science Translational Medicine|October 13, 2021
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseasesXianyuan Xiang, Karin Wind, Thomas Wiedemann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2020
In Vivo Assessment of Neuroinflammation in 4-Repeat TauopathiesCarla Palleis, Julia Sauerbeck, Leonie Beyer, et al.
Journal of Neuroinflammation|January 23, 2024
Associations between sex, body mass index and the individual microglial response in Alzheimer's diseaseGloria Biechele, Boris-Stephan Rauchmann, Daniel Janowitz, et al.
Nature Communications|August 8, 2025
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's diseaseCarolin Meyer, Theresa Niedermeier, Paul L C Feyen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026
Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophyLisa Tagnin, Julia S Dorneich, Marianthi Zeinaki, et al.
Journal of Alzheimer'S Disease : JAD|March 11, 2022
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's DiseaseSteffen Wolfsgruber, Luca Kleineidam, Anne-Sophie Weyrauch, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 12, 2024
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathiesRoxane Dilcher, Stephan Wall, Mattes Groß, et al.
NPJ Digital Medicine|June 10, 2026
Smartphone-based detection of subtle memory decline in prodromal Alzheimer's diseaseSarah E Polk, Lindsay R Clark, Kristin Basche, et al.
Science Translational Medicine|October 13, 2021
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseasesXianyuan Xiang, Karin Wind, Thomas Wiedemann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2020
In Vivo Assessment of Neuroinflammation in 4-Repeat TauopathiesCarla Palleis, Julia Sauerbeck, Leonie Beyer, et al.
Journal of Neuroinflammation|January 23, 2024
Associations between sex, body mass index and the individual microglial response in Alzheimer's diseaseGloria Biechele, Boris-Stephan Rauchmann, Daniel Janowitz, et al.
Nature Communications|August 8, 2025
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's diseaseCarolin Meyer, Theresa Niedermeier, Paul L C Feyen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026
Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophyLisa Tagnin, Julia S Dorneich, Marianthi Zeinaki, et al.
Journal of Alzheimer'S Disease : JAD|March 11, 2022
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's DiseaseSteffen Wolfsgruber, Luca Kleineidam, Anne-Sophie Weyrauch, et al.
Journal of Neuroinflammation|March 11, 2023
[<sup>18</sup>F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human dataAnna Ballweg, Carolin Klaus, Letizia Vogler, et al.
Pageof 11